Is it necessary to check outcomes to improve quality of care? The example of anemia management

Basit Öğe Kaydı
dc.contributor.authorDi Benedetto, Attilio
dc.contributor.authorRichards, Nick
dc.contributor.authorMarcelli, Daniele
dc.contributor.authorBasci, Ali
dc.contributor.authorCesare, Salvatore
dc.contributor.authorPonce, Pedro
dc.contributor.authorScatizzi, Laura
dc.contributor.authorMarotta, Paolo
dc.date.accessioned2019-10-27T19:57:13Z
dc.date.available2019-10-27T19:57:13Z
dc.date.issued2008
dc.departmentEge Üniversitesien_US
dc.descriptionInternational Conference on Survival is not Enough - Quality of Life in CKD -- MAR 07-08, 2007 -- Naples, ITALYen_US
dc.description.abstractThe aim of this study was to verify the importance of continuously monitoring the level of adherence to the anemia guideline recommendations in order to improve not only quality of care but also patient safety. Data presented in this investigation were gained through the FME database EuCliD (R) which contains the clinical data of over 24,000 prevalent patients under treatment at the time of the analysis in 344 dialysis centres in 15 countries. Patient data from 4 countries (United Kingdom, Turkey, Italy, Portugal) was used for this study. The parameter selected was anemia control. The level of hemoglobin (Hb) was considered as the quality indicator for anemia, the target being an Hb level > 11 g/dL, for UK centres the target was > 10 g/dL. All new patients commencing hemodialysis between October 2003 and September 30, 2004 with the previous follow-up of less than one month and without previous blood transfusion were considered. A total of 902 patients were enrolled. The study showed that 4 to 6% of the Italian, Portuguese and British patients treated in FME clinics received a blood transfusion during the first year of follow-up. This is consistent with reports by USRDS that only 3.3% of ESRD patients received at least 1 transfusion per quarter in 1992 after erythropoietin became available and was prescribed to 88% of patients. About 18% Turkish patients, required blood transfusions during the first year of follow-up on hemodialysis, which is more comparable with USRDS data reported in 1989, when 16% of patients needed at least 1 transfusion quarterly. In conclusion, the practice of blood transfusion for hemodialysis patients is still frequent especially in elderly patients.en_US
dc.description.sponsorshipItalian Soc Nephrol, Int Federat Kidney Fdn, European Renal Nephrol, Campania Reg, Natl Comm Bioeth, Italian Govt, Council Minist, Branch Presidencyen_US
dc.identifier.endpageS152en_US
dc.identifier.issn1121-8428
dc.identifier.pmid18446749en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpageS146en_US
dc.identifier.urihttps://hdl.handle.net/11454/40924
dc.identifier.volume21en_US
dc.identifier.wosWOS:000269100100027en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWichtig Editoreen_US
dc.relation.ispartofJournal of Nephrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnemia controlen_US
dc.subjectBlood transfusionsen_US
dc.subjectFirst dialytic yearen_US
dc.subjectElderly peopleen_US
dc.titleIs it necessary to check outcomes to improve quality of care? The example of anemia managementen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu